MINNEAPOLIS, Minnesota, Jan. 24 -- Taft, a law firm, issued the following news:

Taft is pleased to have acted as legal counsel to Nimble Therapeutics in its sale to AbbVie (NYSE: ABBV).

Nimble is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics.

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products